Tailwind is an at-home solution that helps improve arm function and range of motion for people with stroke or other brain injury. The science behind Encore Path's Tailwind was researched at the University of Maryland Medical School. Published studies demonstrate that stroke survivors with moderate paralysis improved their arm function when using the Tailwind device.
According to published studies, the Tailwind’s primary medical innovation is controlling the independent movement of the arms by reactivating central neuromuscular pathways. The studies report that dormant pathways are reactivated after repetitive training on Tailwind. After several 5 minute training sessions over a 6 week period, marked improvement in movement and function are noticeable in individuals as much as 20 years post-stroke. Learn more in the sections below:
- Tailwind Demonstrations: Watch real patients use Tailwind through multiple video demonstrations and hear about their real-life experiences.
- A Product That Stands Apart: in the comfort of your own home, Tailwind treats coordination disorders by implementing a "sound-to-brain" neural pathway retraining approach that is theorized to help patients with mild stroke symptoms achieve life-altering results.
- Development of Tailwind: The Tailwind’s primary medical innovation is controlling the independent movement of the arms by reactivating central neuromuscular pathways. Dormant pathways are reactivated after repetitive training on Tailwind.
- The Science Behind Tailwind: University of Maryland Medical School inventors and researchers devised the science behind how Tailwind improves arm function.
- Published Scientific Studies: "In this small randomized controlled study, improvements in both spatial and temporal control of the arms during bilateral reaching tasks after 6 weeks of BATRAC training compared to 6 weeks of unilateral arm training were demonstrated." Read about this study and many more.
- History of Tailwind: Following the invention of the Tailwind device, Encore Path looked at a number of engineering firms to develop and refine the device prior to product launch. After meeting engineers from Sagentia at the Medical Device and Manufacturing (MD&M) Conference in New York in June 2006, the company decided to ask Sagentia to re-engineer the device.